StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) company profile

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

About MiMedx

Surgical & Medical Instruments & Apparatus, SIC 3841

MIMEDX develops and manufactures regenerative biomaterial products, primarily human placental allografts, animal-derived xenografts, and advanced wound dressings. The company operates across wound care, surgical specialties, and burn treatment sectors. Its product portfolio includes human placental membrane allografts, bovine collagen matrices, autologous platelet-rich plasma gels, and peptide matrices intended to assist in healing chronic wounds, surgical recovery, and internal tissue reinforcement. Customers include clinicians, hospitals, private physician practices, wound care clinics, ambulatory surgery centers, nursing homes, and federal healthcare facilities such as the Department of Veterans Affairs.

The company conducts most of its commercial business in the United States and distributes products internationally, including in Japan. It processes donated human birth tissue from a nationwide network of partner hospitals at manufacturing facilities located in Marietta and Kennesaw, Georgia, while the provided text does not state its headquarters location. Through December 2025, the business has supplied several million allografts and maintains nearly three hundred issued and pending patents worldwide.

Summary of the business section of MiMedx's latest annual report, written by StockData.

Company profile

Company

Legal name
MiMedx Group, Inc.
Headquarters
Marietta, GA
Address
1775 W Oak Commons Court, Ne 30062
Phone
(770) 651-9100
Website
mimedx.com
Employees
808, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Atlanta, Georgia

Stock & identifiers

Ticker
MDXG
Exchange
Nasdaq
IPO date
Feb 12, 2008
Shares outstanding
146M, Oct 22, 2026
Public float
$719.00M, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1376339
CUSIP
602496101
ISIN
US6024961012
FIGI
BBG000RJ6FL5
Share class FIGI
BBG001STPW96
EIN
26-2792552

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Rice DougChief Financial Officer399,566
Kimberly Maersk-MollerChief Commercial Officer309,630
William Frank Hulse IVGeneral Counsel and CAO543,195
Ricci S. WhitlowChief Operating Officer462,825
Joseph H. CapperChief Executive Officer904,656
James L. BiermanDirector263,684
Tiffany OlsonDirector108,510
William A. HawkinsDirector255,431
Todd NewtonDirector463,684
Dorothy E. PuhyDirector108,510
M. Kathleen BehrensDirector212,771
Cato T. LaurencinDirector181,923

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$7.18M-$14.96M$2.10M$75–
FY2024
Joseph H.Capper
$1.39M$5.12M$2.77M$106–
FY2024
K.Todd Newton
–$487.29K$2.77M$106–
FY2023
Joseph Capper
$20.83M$37.01M$2.52M$97–
FY2023
Joseph H.Capper
$20.76M$36.93M$2.52M$97–
FY2023
K.Todd Newton
$295.29K$487.29K$2.52M$97–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Joseph H. Capper
Chief Executive Officer
$768.17K$4.70M$819.42K$887.80K$7.81K$7.18M+417%
Doug Rice
Chief Financial Officer
$540.00K$966.64K$168.57K$372.60K$71.92K$2.12M-11%
William F. Hulse IV
General Counsel and Chief Administrative Officer
$546.00K$977.38K$170.44K$376.74K$74.93K$2.15M-11%
Ricci S. Whitlow
EVP & Chief Operating Officer
$540.00K$966.64K$168.57K$372.60K$13.14K$2.06M-10%
Kimberly Maersk-Moller
Chief Commercial Officer
$540.00K$966.64K$168.57K$372.60K$9.04K$2.06M-48%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 808 full time employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 25, 2026MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 30, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 2, 2020ListingRegistration of securities on an exchange (Form 8-A)
May 11, 2020Late filingNotification of late filing
Mar 18, 2020Late filingNotification of late filing
Nov 12, 2019Late filingNotification of late filing
Aug 9, 2019Late filingNotification of late filing
May 29, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
May 10, 2019Late filingNotification of late filing
Mar 1, 2019Late filingNotification of late filing
Feb 26, 2019DelistingNotice of delisting from exchange (Form 25)
Feb 25, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 7, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 13, 2018Late filingNotification of late filing
Nov 7, 2018Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 13, 2018Late filingNotification of late filing
May 18, 2018Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 10, 2018Late filingNotification of late filing
Mar 5, 2018Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 2, 2018Late filingNotification of late filing
Oct 5, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 10, 2017Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 31, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 13, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 22, 2013ListingRegistration of securities on an exchange (Form 8-A)
Apr 1, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 16, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 14, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 22, 2009Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 18, 2009Late filingNotification of late filing

See a number that looks wrong?